Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $16.62 and traded as low as $16.19. Getinge AB (publ) shares last traded at $16.37, with a volume of 68,270 shares.
Getinge AB (publ) Price Performance
The stock's 50 day simple moving average is $16.56 and its two-hundred day simple moving average is $18.42. The firm has a market cap of $4.44 billion, a P/E ratio of 27.65 and a beta of 0.79.
Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) last released its earnings results on Friday, October 18th. The company reported $0.21 EPS for the quarter. The firm had revenue of $755.49 million for the quarter. Getinge AB (publ) had a return on equity of 8.27% and a net margin of 5.04%.
Getinge AB (publ) Company Profile
(
Get Free Report)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Further Reading
Before you consider Getinge AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge AB (publ) wasn't on the list.
While Getinge AB (publ) currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
